Skip to content

60 DEGREES PHARMACEUTICALS, INC.: 10-Q filed 2025-08-13

What 60 DEGREES PHARMACEUTICALS, INC. reported in its quarterly report filed 2025-08-13 (fiscal Q2 2025): 49 published measures, 147 facts as tagged in accession 0001554855-25-001009.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-13
Fiscal period
fiscal Q2 2025
Accession
0001554855-25-001009 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All 60 DEGREES PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-304,181,938USD
At 2024-12-315,759,345USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-301,836,234USD
At 2024-12-311,804,339USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-302,428,254USD
At 2024-12-314,035,600USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-301,966,930USD
At 2024-12-311,659,353USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,733,726USD91
2025-01-01 to 2025-06-30-3,610,275USD181
2024-04-01 to 2024-06-30-4,172,755USD91
2024-01-01 to 2024-06-30-3,742,285USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-3,047,494USD181
2024-01-01 to 2024-06-30-2,328,650USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-06-3050,001USD181
2024-01-01 to 2024-06-3090,000USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-04-01 to 2025-06-30100,932USD91
2025-01-01 to 2025-06-30264,484USD181
2024-04-01 to 2024-06-30124,972USD91
2024-01-01 to 2024-06-30230,646USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-301,696,899USD181
2024-01-01 to 2024-06-301,902,426USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-06-301,650,834USD181
2024-01-01 to 2024-06-30-140,373USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-44,138,232USD
At 2024-12-31-40,527,957USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,472,891shares91
2025-01-01 to 2025-06-301,378,700shares181
2024-04-01 to 2024-06-30202,967shares91
2024-01-01 to 2024-06-30185,861shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,472,891shares91
2025-01-01 to 2025-06-301,378,700shares181
2024-04-01 to 2024-06-30202,967shares91
2024-01-01 to 2024-06-30185,861shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1.25USD/shares91
2025-01-01 to 2025-06-30-2.79USD/shares181
2024-04-01 to 2024-06-30-21.12USD/shares91
2024-01-01 to 2024-06-30-21.41USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1.25USD/shares91
2025-01-01 to 2025-06-30-2.79USD/shares181
2024-04-01 to 2024-06-30-21.12USD/shares91
2024-01-01 to 2024-06-30-21.41USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,500USD91
2025-01-01 to 2025-06-301,563USD181
2024-04-01 to 2024-06-30438USD91
2024-01-01 to 2024-06-30501USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-30193,879USD
At 2024-12-31149,808USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,604,828USD91
2025-01-01 to 2025-06-30-3,515,703USD181
2024-04-01 to 2024-06-30-4,188,750USD91
2024-01-01 to 2024-06-30-5,531,198USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-303,844,355USD
At 2024-12-315,386,277USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-301,690,757USD
At 2024-12-311,657,220USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-06-30295,034USD
At 2024-12-31486,748USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,862,648USD91
2025-01-01 to 2025-06-303,956,534USD181
2024-04-01 to 2024-06-304,224,886USD91
2024-01-01 to 2024-06-305,637,202USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-06-30799,421USD
At 2024-12-31442,764USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-3050,881USD91
2025-01-01 to 2025-06-30141,161USD181
2024-04-01 to 2024-06-3035,408USD91
2024-01-01 to 2024-06-3075,645USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-04-01 to 2025-06-3050,051USD91
2025-01-01 to 2025-06-30123,323USD181
2024-04-01 to 2024-06-3089,564USD91
2024-01-01 to 2024-06-30155,001USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-04-01 to 2025-06-30249,884USD91
2025-01-01 to 2025-06-30657,506USD181
2024-04-01 to 2024-06-303,095,326USD91
2024-01-01 to 2024-06-303,432,508USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-301,472,891shares
At 2024-12-31566,908shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-06-301,966,930USD
At 2024-12-311,659,353USD
At 2024-06-301,576,602USD
At 2023-12-312,142,485USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-3036,856,091USD
At 2024-12-3134,860,590USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-06-30142,809USD
At 2024-12-31135,471USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-06-302,345,704USD
At 2025-03-314,028,889USD
At 2024-12-313,955,006USD
At 2024-06-302,959,384USD
At 2024-03-317,125,478USD
At 2023-12-314,798,096USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-06-30150,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-30357,339USD
At 2024-12-31299,241USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-30163,460USD
At 2024-12-31149,433USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-06-30143,704USD
At 2024-12-31157,084USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-06-30143,704USD
At 2024-12-31223,260USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-06-30782,970USD
At 2024-12-311,068,940USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,733,430USD91
2025-01-01 to 2025-06-30-3,610,668USD181
2024-04-01 to 2024-06-30-4,173,788USD91
2024-01-01 to 2024-06-30-3,745,740USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,734,930USD91
2025-01-01 to 2025-06-30-3,612,231USD181
2025-01-01 to 2025-03-31-1,877,301USD90
2024-04-01 to 2024-06-30-4,174,226USD91
2024-01-01 to 2024-06-30-3,746,241USD182
2024-01-01 to 2024-03-31427,985USD91

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,716,484USD91
2025-01-01 to 2025-06-30-3,602,937USD181
2024-04-01 to 2024-06-30-4,169,618USD91
2024-01-01 to 2024-06-30-3,743,042USD182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,843,189USD91
2025-01-01 to 2025-06-30-3,847,800USD181
2024-04-01 to 2024-06-30-4,287,499USD91
2024-01-01 to 2024-06-30-3,978,804USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,612,764USD91
2025-01-01 to 2025-06-303,299,028USD181
2024-04-01 to 2024-06-301,129,560USD91
2024-01-01 to 2024-06-302,204,694USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-06-3015,930USD181
2024-01-01 to 2024-06-301,943USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-04-01 to 2025-06-309,236USD91
2025-01-01 to 2025-06-3015,930USD181
2024-04-01 to 2024-06-301,536USD91
2024-01-01 to 2024-06-301,943USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-04-01 to 2025-06-3010,442USD91
2025-01-01 to 2025-06-3020,545USD181
2024-04-01 to 2024-06-309,472USD91
2024-01-01 to 2024-06-3017,679USD182

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,221USD91
2025-01-01 to 2025-06-303,011USD181
2024-04-01 to 2024-06-303,621USD91
2024-01-01 to 2024-06-305,023USD182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-04-01 to 2025-06-3013,066USD91
2025-01-01 to 2025-06-3043,388USD181
2024-04-01 to 2024-06-3019,684USD91
2024-01-01 to 2024-06-3050,735USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-191,714USD181
2024-01-01 to 2024-06-3065,038USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30356,657USD181
2024-01-01 to 2024-06-30-40,149USD182

Inspect the source

Entity
60 DEGREES PHARMACEUTICALS, INC. / CIK 0001946563
Captured
2026-09-21T17:41:45.368Z
SEC response SHA-256
b95fff66e7a953f292c25a6ce30bc53c9746adb7dec7916bb5971972be8b9ae4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001946563.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))